Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review
Objective
Osteoarthritis (OA) is one of the leading causes of disability in the adult population. Common nonoperative treatment options include nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids, and intra-articular injections of hyaluronic acid (HA). HA is found intrinsically within the knee joint providing viscoelastic properties to the synovial fluid. HA therapy provides anti-inflammatory relief through a number of different pathways, including the suppression of pro-inflammatory cytokines and chemokines.
Methods
We conducted a systematic review to summarize the published literature on the anti-inflammatory properties of hyaluronic acid in osteoarthritis. Included articles were categorized based on the primary anti-inflammatory responses described within them, by the immediate cell surface receptor protein assessed within the article, or based on the primary theme of the article. Key findings aimed to describe the macromolecules and inflammatory-mediated responses associated with the cell transmembrane receptors.
Results
Forty-eight articles were included in this systematic review that focused on the general anti-inflammatory effects of HA in knee OA, mediated through receptor-binding relationships with cluster determinant 44 (CD44), toll-like receptor 2 (TLR-2) and 4 (TLR-4), intercellular adhesion molecule-1 (ICAM-1), and layilin (LAYN) cell surface receptors. Higher molecular weight HA (HMWHA) promotes anti-inflammatory responses, whereas short HA oligosaccharides produce inflammatory reactions.
Conclusions
Intra-articular HA is a viable therapeutic option in treating knee OA and suppressing inflammatory responses. HMWHA is effective in suppressing the key macromolecules that elicit the inflammatory response by short HA oligosaccharides.
Top-30
Journals
|
2
4
6
8
10
12
14
|
|
|
International Journal of Biological Macromolecules
13 publications, 9.63%
|
|
|
International Journal of Molecular Sciences
4 publications, 2.96%
|
|
|
Pharmaceutics
3 publications, 2.22%
|
|
|
Journal of Experimental Orthopaedics
3 publications, 2.22%
|
|
|
Carbohydrate Polymers
3 publications, 2.22%
|
|
|
Journal of Clinical Medicine
3 publications, 2.22%
|
|
|
Biomedicines
3 publications, 2.22%
|
|
|
Pharmaceuticals
2 publications, 1.48%
|
|
|
Biomolecules
2 publications, 1.48%
|
|
|
Polymers
2 publications, 1.48%
|
|
|
BMC Musculoskeletal Disorders
2 publications, 1.48%
|
|
|
Journal of Orthopaedic Research
2 publications, 1.48%
|
|
|
Advanced healthcare materials
2 publications, 1.48%
|
|
|
Journal of Biomedical Science
2 publications, 1.48%
|
|
|
Biomedical and Biotechnology Research Journal (BBRJ)
2 publications, 1.48%
|
|
|
Bioengineering
2 publications, 1.48%
|
|
|
International Journal of Pharmaceutics
2 publications, 1.48%
|
|
|
Biomaterials Science
2 publications, 1.48%
|
|
|
Microscopy and Microanalysis
1 publication, 0.74%
|
|
|
Military Medical Research
1 publication, 0.74%
|
|
|
Molecular Medicine Reports
1 publication, 0.74%
|
|
|
Therapeutic Advances in Musculoskeletal Disease
1 publication, 0.74%
|
|
|
Cells
1 publication, 0.74%
|
|
|
Applied Sciences (Switzerland)
1 publication, 0.74%
|
|
|
Frontiers in Pharmacology
1 publication, 0.74%
|
|
|
Frontiers in Molecular Biosciences
1 publication, 0.74%
|
|
|
Frontiers in Bioengineering and Biotechnology
1 publication, 0.74%
|
|
|
Antioxidants
1 publication, 0.74%
|
|
|
Annals of Biomedical Engineering
1 publication, 0.74%
|
|
|
2
4
6
8
10
12
14
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
37 publications, 27.41%
|
|
|
MDPI
26 publications, 19.26%
|
|
|
Springer Nature
19 publications, 14.07%
|
|
|
Wiley
16 publications, 11.85%
|
|
|
Taylor & Francis
5 publications, 3.7%
|
|
|
SAGE
4 publications, 2.96%
|
|
|
American Chemical Society (ACS)
4 publications, 2.96%
|
|
|
Frontiers Media S.A.
3 publications, 2.22%
|
|
|
Oxford University Press
2 publications, 1.48%
|
|
|
Georg Thieme Verlag KG
2 publications, 1.48%
|
|
|
Medknow
2 publications, 1.48%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 1.48%
|
|
|
Spandidos Publications
1 publication, 0.74%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.74%
|
|
|
Hindawi Limited
1 publication, 0.74%
|
|
|
Science Alert
1 publication, 0.74%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.74%
|
|
|
AME Publishing Company
1 publication, 0.74%
|
|
|
Volgograd State Medical University
1 publication, 0.74%
|
|
|
Samara State Medical University
1 publication, 0.74%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.74%
|
|
|
A and V Publications
1 publication, 0.74%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.